References:
Agata Y, Kawasaki A, et al. (1996). Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8(5): 765-72.
Ansari M, Salama AD, et al. 2003. The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice. JEM. 198:63-69 (IH/F, FA, PubMed).
Nishimura H, Agata Y, et al. (1996). Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol 8(5): 773-80.
Nishimura, H., T. Okazaki, et al. (2001). Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291(5502): 319-22.
Freeman, G. J., A. J. Long, et al. (2000). Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192(7): 1027-34.
Nishimura, H., T. Honjo, et al. (2000). Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice. J Exp Med 191(5): 891-8.
Nishimura, H., N. Minato, et al. (1998). Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 10(10): 1563-72.
Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, Khoury SJ. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med. 2003 Jul 7;198(1):71-8. (IH/F, FA,PubMed)